GLP-3 (Reta)
Typical Benefits
- Multi-receptor incretin research
- Appetite- and satiety-pathway research
- Body-weight endpoint research
- Glycaemic and lipid-endpoint research
- Body-composition research
Research context only: These topics identify areas of study. They are not verified benefits, evidence for this listed product, medical advice, safety guidance, or suitability guidance.
Reported COA results
- Peptide Content
- 93.6%
- Purity
- 99.1%

















